Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aflibercept

Brand: Eylea¬ģ
NICE TA: 346
Indication: Diabetic Macular Oedema (NICE TA346)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Aflibercept is recommended as an option for treating visual impairment caused by diabetic macular oedema if the eye has a central retinal thickness of 400 micrometres or more at the start of treatment

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA 346- Aflibercept for treating diabetic macular oedema

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red